Maxillary sinus augmentation with deproteinized bovine bone (Bio-Oss) and Impladent dental implant system. Part II. Evaluation of deprotienized bovine bone (Bio-Oss) and implant surface.
The objective of this clinical study was to determine the predictability of endosseous implant placed in a maxillary sinus augmented with deproteinized bovine bone (Bio-Oss). A total of 185 implants (109 titanium and 76 hydroxyapatite-coated) were placed in 77 patients representing 92 sinuses either a one- or two-stage surgical technique. A mixture of venous patient's blood and Bio-Oss was used alone within 20 sinuses (Group 1), or in combination with autogenous bone within 72 sinuses (Group 2). Thirty-nine implants were placed in Group 1 and 147 implants were inserted in Group 2. The grafted sinuses were evaluated clinically and radiographically at second stage surgery. According to certain criteria, of the implants placed, only two titanium implants (1.08%) failed with 98.91% implant survival. There was no statistically variable difference for the use of hydroxyapatite-coated or titanium implants. The two failed implants were from Group 2. No clinical benefit has been achieved from the combination with autogenous bone (P<0.05). All the grafted sinuses were sufficient to place dental implants of at least 12 mm length (100% graft success). The results of this short-term study support the hypothesis that Bio-Oss can be a suitable material for sinus augmentation.
Kasabah
Samer
S
Charles University in Prague, Faculty of Medicine in Hradec Králové, Department of Dentistry, Centre of Dental Implantology, Czech Republic. skasabah@hotmail.com
Simůnek
Antonín
A
Krug
Jirí
J
Lecaro
Miguel Cevallos
MC
D000540:Alveolar Ridge Augmentation / Q000379:methods*; D018786:Bone Substitutes / Q000008:administration & dosage*; D016025:Bone Transplantation; D003758:Dental Implantation, Endosseous / Q000295:instrumentation; D005260:Female; D006801:Humans; D008297:Male; D008443:Maxillary Sinus / Q000601:surgery*; D008903:Minerals / Q000008:administration & dosage*; D011183:Postoperative Complications
C077540:Bio-Oss; D018786:Bone Substitutes; D008903:Minerals